2025-520616-33-00招募中1 期
A study comparing different RO7269162 capsules and investigating the effect of food on the uptake, breakdown, and elimination of RO7269162 in Healthy Participants
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 48
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Trial Information System - TISL
Scientific
F. Hoffmann-La Roche AG
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants with Type 2 Diabetes Mellitus(T2DM) and Overweight or Obesity2025-521401-41-00F. Hoffmann-La Roche AG30
招募中
1 期
A Phase I Study of RO7589831 Alone and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors2023-503170-20-01F. Hoffmann-La Roche AG46
招募中
1 期
A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.2024-511110-21-00F. Hoffmann-La Roche AG140
招募中
4 期
A study to compare the absorption of two tablet strengths with the absorption of a solution.Parkinson's Disease2024-519835-41-00Arvinas Operations Inc.18
招募中
1 期
First-in-Human Study of RO78126532025-522101-37-00F. Hoffmann-La Roche AG12